A framework to understand the variations of PSD-95 expression in brain aging and in Alzheimer's disease

Ageing Research Reviews

Volumn 18, Issue , 2014, Pages 86-94

  Savioz, Armand ^a,b   Leuba, Geneviève ^c   Vallet, Philippe G ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Aging; Alzheimer's disease; Depression; Environmental enrichment; PSD 95; Transgenic mice models

Indexed keywords

POSTSYNAPTIC DENSITY PROTEIN 95; DLG4 PROTEIN, HUMAN; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

AGING; ALZHEIMER DISEASE; DISEASE COURSE; ENDOPHENOTYPE; HUMAN; NONHUMAN; PROTEIN EXPRESSION; REVIEW; TEMPORAL CORTEX; AGE; ANIMAL; BIOLOGICAL MODEL; BRAIN; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHENOTYPE; PSYCHOLOGY; TRANSGENIC MOUSE;

AGE FACTORS; AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PHENOTYPE;

EID: 84907961780     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.09.004     Document Type: Review

References (72)

1. Alldred M.J., Duff K.E., Ginsberg S.D. Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction. Neurobiol. Dis. 2012, 45:751-762.
2. Almeida C.G., Tampellini D., Takahashi R.H., Greengard P., Lin M.T., Snyder E.M., Gouras G.K. Beta-amyloid accumulation in APP mutant neurons reduces PSD-95 and GluR1 in synapses. Neurobiol. Dis. 2005, 20:187-198.
3. Counts S.E., Alldred M.J., Che S., Ginsberg S.D., Mufson E.J. Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment. Neuropharmacology 2014, 79:172-179.
4. Counts S.E., Nadeem M., Lad S.P., Wuu J., Mufson E.J. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J. Neuropathol. Exp. Neurol. 2006, 65:592-601.
5. Dietrich M.O., Mantese C.E., Porciuncula L.O., Ghisleni G., Vinade L., Souza D.O., Portela L.V. Exercise affects glutamate receptors in postsynaptic densities from cortical mice brain. Brain Res. 2005, 1065:20-25.
6. Dinamarca M.C., Rios J.A., Inestrosa N.C. Postsynaptic receptors for amyloid-beta oligomers as mediators of neuronal damage in Alzheimer's disease. Front. Physiol. 2012, 3:464.
7. Diniz B.S., Butters M.A., Albert S.M., Dew M.A., Reynolds C.F. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br. J. Psychiatry 2013, 202:329-335.
8. Dracheva S., Marras S.A., Elhakem S.L., Kramer F.R., Davis K.L., Haroutunian V. N-methyl-d-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am. J. Psychiatry 2001, 158:1400-1410.
9. Feyissa A.M., Chandran A., Stockmeier C.A., Karolewicz B. Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:70-75.
10. Fugistier P., Vallet P.G., Leuba G., Piotton F., Marin P., Bouras C., Savioz A. A comparison of frailty of primary neurons, embryonic, and aging mouse cortical layers. Neurobiol. Aging 2014, 35:322-330.
11. Gong Y., Lippa C.F. Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias. Am. J. Alzheimers Dis. Other Demen. 2010, 25:547-555.
12. Gong Y., Lippa C.F., Zhu J., Lin Q., Rosso A.L. Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease. Brain Res. 2009, 1292:191-198.
13. Gylys K.H., Fein J.A., Yang F., Wiley D.J., Miller C.A., Cole G.M. Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am. J. Pathol. 2004, 165:1809-1817.
14. Han K., Kim E. Synaptic adhesion molecules and PSD-95. Prog. Neurobiol. 2008, 84:263-283.
15. Head E., Corrada M.M., Kahle-Wrobleski K., Kim R.C., Sarsoza F., Goodus M., Kawas C.H. Synaptic proteins, neuropathology and cognitive status in the oldest-old. Neurobiol. Aging 2009, 30:1125-1134.
16. Hu S., Ying Z., Gomez-Pinilla F., Frautschy S.A. Exercise can increase small heat shock proteins (sHSP) and pre- and post-synaptic proteins in the hippocampus. Brain Res. 2009, 1249:191-201.
17. Imfeld P., Bodmer M., Schuerch M., Jick S.S., Meier C.R. Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis. Epilepsia 2013, 54:700-707.
18. Ingelsson M., Fukumoto H., Newell K.L., Growdon J.H., Hedley-Whyte E.T., Frosch M.P., Albert M.S., Hyman B.T., Irizarry M.C. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 2004, 62:925-931.
19. Ittner L.M., Ke Y.D., Delerue F., Bi M., Gladbach A., van Eersel J., Wolfing H., Chieng B.C., Christie M.J., Napier I.A., Eckert A., Staufenbiel M., Hardeman E., Gotz J. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models. Cell 2010, 142:387-397.
20. Jernigan C.S., Goswami D.B., Austin M.C., Iyo A.H., Chandran A., Stockmeier C.A., Karolewicz B. The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1774-1779.
21. Jones S.B., Lanford G.W., Chen Y.H., Morabito M., Kim K., Lu Q. Glutamate-induced delta-catenin redistribution and dissociation from postsynaptic receptor complexes. Neuroscience 2002, 115:1009-1021.
22. Karolewicz B., Szebeni K., Gilmore T., Maciag D., Stockmeier C.A., Ordway G.A. Elevated levels of NR2A and PSD-95 in the lateral amygdala in depression. Int. J. Neuropsychopharmacol. 2009, 12:143-153.
23. Keith D., El-Husseini A. Excitation control: balancing PSD-95 function at the synapse. Front. Mol. Neurosci. 2008, 1:4.
24. Kim E., Sheng M. The postsynaptic density. Curr. Biol. 2009, 19:R723-R724.
25. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., Lambert M.P., Velasco P.T., Bigio E.H., Finch C.E., Krafft G.A., Klein W.L. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 2004, 24:10191-10200.
26. Leuba G., Savioz A., Vernay A., Carnal B., Kraftsik R., Tardif E., Riederer I., Riederer B.M. Differential changes in synaptic proteins in the Alzheimer frontal cortex with marked increase in PSD-95 postsynaptic protein. J. Alzheimers Dis. 2008, 15:139-151.
27. Leuba G., Vernay A., Kraftsik R., Tardif E., Riederer B.M., Savioz A. Pathological reorganization of NMDA receptors subunits and postsynaptic protein PSD-95 distribution in Alzheimer's disease. Curr. Alzheimer Res. 2014, 11:86-96.
28. Leuba G., Vernay A., Zimmermann V., Saini K., Kraftsik R., Savioz A. Differential damage in the frontal cortex with aging sporadic and familial Alzheimer's disease. Brain Res. Bull. 2009, 80:196-202.
29. Leuba G., Walzer C., Vernay A., Carnal B., Kraftsik R., Piotton F., Marin P., Bouras C., Savioz A. Postsynaptic density protein PSD-95 expression in Alzheimer's disease and okadaic acid induced neuritic retraction. Neurobiol. Dis. 2008, 30:408-419.
30. Liang D., Han G., Feng X., Sun J., Duan Y., Lei H. Concerted perturbation observed in a hub network in Alzheimer's disease. PLoS ONE 2012, 7:e40498.
31. Lin N., Pan X.D., Chen A.Q., Zhu Y.G., Wu M., Zhang J., Chen X.C. Tripchlorolide improves age-associated cognitive deficits by reversing hippocampal synaptic plasticity impairment and NMDA receptor dysfunction in SAMP8 mice. Behav. Brain Res. 2014, 258:8-18.
32. Liu J., Chang L., Roselli F., Almeida O.F., Gao X., Wang X., Yew D.T., Wu Y. Amyloid-beta induces caspase-dependent loss of PSD-95 and synaptophysin through NMDA receptors. J. Alzheimers Dis. 2010, 22:541-556.
33. Love S., Siew L.K., Dawbarn D., Wilcock G.K., Ben-Shlomo Y., Allen S.J. Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiol. Aging 2006, 27:797-803.
34. Majdi M., Ribeiro-da-Silva A., Cuello A.C. Cognitive impairment and transmitter-specific pre- and postsynaptic changes in the rat cerebral cortex during ageing. Eur. J. Neurosci. 2007, 26:3583-3596.
35. Markov N.T., Kennedy H. The importance of being hierarchical. Curr. Opin. Neurobiol. 2013, 23:187-194.
36. Migaud M., Charlesworth P., Dempster M., Webster L.C., Watabe A.M., Makhinson M., He Y., Ramsay M.F., Morris R.G., Morrison J.H., O'Dell T.J., Grant S.G. Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 1998, 396:433-439.
37. Murakoshi H., Yasuda R. Postsynaptic signaling during plasticity of dendritic spines. Trends Neurosci. 2012, 35:135-143.
38. Nithianantharajah J., Levis H., Murphy M. Environmental enrichment results in cortical and subcortical changes in levels of synaptophysin and PSD-95 proteins. Neurobiol. Learn. Mem. 2004, 81:200-210.
39. Nyffeler M., Zhang W.N., Feldon J., Knuesel I. Differential expression of PSD proteins in age-related spatial learning impairments. Neurobiol. Aging 2007, 28:143-155.
40. Okabe S. Molecular anatomy of the postsynaptic density. Mol. Cell. Neurosci. 2007, 34:503-518.
41. Park C.S., Elgersma Y., Grant S.G., Morrison J.H. alpha-isoform of calcium-calmodulin-dependent protein kinase II and postsynaptic density protein 95 differentially regulate synaptic expression of NR2A- and NR2B-containing N-methyl-d-aspartate receptors in hippocampus. Neuroscience 2008, 151:43-55.
42. Petralia R.S. Distribution of extrasynaptic NMDA receptors on neurons. ScientificWorldJournal 2012, 2012:267120.
43. Pham E., Crews L., Ubhi K., Hansen L., Adame A., Cartier A., Salmon D., Galasko D., Michael S., Savas J.N., Yates J.R., Glabe C., Masliah E. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J. 2010, 277:3051-3067.
44. Preissmann D., Leuba G., Savary C., Vernay A., Kraftsik R., Riederer I.M., Schenk F., Riederer B.M., Savioz A. Increased postsynaptic density protein-95 expression in the frontal cortex of aged cognitively impaired rats. Exp. Biol. Med. (Maywood) 2012, 237:1331-1340.
45. Proctor D.T., Coulson E.J., Dodd P.R. Reduction in post-synaptic scaffolding PSD-95 and SAP-102 protein levels in the Alzheimer inferior temporal cortex is correlated with disease pathology. J. Alzheimers Dis. 2010, 21:795-811.
46. Proctor D.T., Coulson E.J., Dodd P.R. Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease. Prog. Neurobiol. 2011, 93:509-521.
47. Revilla S., Sunol C., Garcia-Mesa Y., Gimenez-Llort L., Sanfeliu C., Cristofol R. Physical exercise improves synaptic dysfunction and recovers the loss of survival factors in 3xTg-AD mouse brain. Neuropharmacology 2014, 81:55-63.
48. Roselli F., Tirard M., Lu J., Hutzler P., Lamberti P., Livrea P., Morabito M., Almeida O.F. Soluble beta-amyloid 1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J. Neurosci. 2005, 25:11061-11070.
49. Savioz A., Leuba G., Vallet P.G., Walzer C. Contribution of neural networks to Alzheimer disease's progression. Brain Res. Bull. 2009, 80:309-314.
50. Scheff S.W., Price D.A., Schmitt F.A., Roberts K.N., Ikonomovic M.D., Mufson E.J. Synapse stability in the precuneus early in the progression of Alzheimer's disease. J. Alzheimers Dis. 2013, 35:599-609.
51. Shao C.Y., Mirra S.S., Sait H.B., Sacktor T.C., Sigurdsson E.M. Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced Abeta and tau pathology in transgenic mouse models of Alzheimer's disease. Acta Neuropathol. 2011, 122:285-292.
52. Sheng M., Kim M.J. Postsynaptic signaling and plasticity mechanisms. Science 2002, 298:776-780.
53. Shimada A., Keino H., Satoh M., Kishikawa M., Hosokawa M. Age-related loss of synapses in the frontal cortex of SAMP10 mouse: a model of cerebral degeneration. Synapse 2003, 48:198-204.
54. Sivanesan S., Tan A., Rajadas J. Pathogenesis of Abeta oligomers in synaptic failure. Curr. Alzheimer Res. 2013, 10:316-323.
55. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 2005, 8:1051-1058.
56. Spires T.L., Meyer-Luehmann M., Stern E.A., McLean P.J., Skoch J., Nguyen P.T., Bacskai B.J., Hyman B.T. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci. 2005, 25:7278-7287.
57. Sultana R., Banks W.A., Butterfield D.A. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease. J. Neurosci. Res. 2010, 88:469-477.
58. Tampellini D., Magrane J., Takahashi R.H., Li F., Lin M.T., Almeida C.G., Gouras G.K. Internalized antibodies to the Abeta domain of APP reduce neuronal Abeta and protect against synaptic alterations. J. Biol. Chem. 2007, 282:18895-18906.
59. VanGuilder H.D., Farley J.A., Yan H., Van Kirk C.A., Mitschelen M., Sonntag W.E., Freeman W.M. Hippocampal dysregulation of synaptic plasticity-associated proteins with age-related cognitive decline. Neurobiol. Dis. 2011, 43:201-212.
60. Vickers C.A., Stephens B., Bowen J., Arbuthnott G.W., Grant S.G., Ingham C.A. Neurone specific regulation of dendritic spines in vivo by post synaptic density 95 protein (PSD-95). Brain Res. 2006, 1090:89-98.
61. Xu W. PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) and synaptic plasticity. Curr. Opin. Neurobiol. 2011, 21:306-312.
62. Xu X., Ye L., Ruan Q. Environmental enrichment induces synaptic structural modification after transient focal cerebral ischemia in rats. Exp. Biol. Med. (Maywood) 2009, 234:296-305.
63. Yang X., Yang Y., Liu J., Li G., Yang E. Increased phosphorylation of tau and synaptic protein loss in the aged transgenic mice expressing familiar Alzheimer's disease-linked presenilin 1 mutation. Neurochem. Res. 2012, 37:15-22.
64. Ying Z., Bingaman W., Najm I.M. Increased numbers of coassembled PSD-95 to NMDA-receptor subunits NR2B and NR1 in human epileptic cortical dysplasia. Epilepsia 2004, 45:314-321.
65. Yokoi N., Fukata M., Fukata Y. Synaptic plasticity regulated by protein-protein interactions and posttranslational modifications. Int. Rev. Cell Mol. Biol. 2012, 297:1-43.
66. Yoshii A., Constantine-Paton M. BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation. Nat. Neurosci. 2007, 10:702-711.
67. Zempel H., Luedtke J., Kumar Y., Biernat J., Dawson H., Mandelkow E., Mandelkow E.M. Amyloid-beta oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastin. EMBO J. 2013, 32:2920-2937.
68. Zempel H., Thies E., Mandelkow E., Mandelkow E.M. Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines. J. Neurosci. 2010, 30:11938-11950.
69. Zhang Y., Zu X., Luo W., Yang H., Luo G., Zhang M., Tang S. Social isolation produces anxiety-like behaviors and changes PSD-95 levels in the forebrain. Neurosci. Lett. 2012, 514:27-30.
70. Zhao H., Li Q., Zhang Z., Pei X., Wang J., Li Y. Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus. Brain Res. 2009, 1256:111-122.
71. Zheng C.Y., Seabold G.K., Horak M., Petralia R.S. MAGUKs, synaptic development, and synaptic plasticity. Neuroscientist 2011, 17:493-512.
72. Zufferey V., Vallet P.G., Moeri M., Moulin-Sallanon M., Piotton F., Marin P., Savioz A. Maladaptive exploratory behavior and neuropathology of the PS-1 P117L Alzheimer transgenic mice. Brain Res. Bull. 2013, 94:17-22.